CBIO
Crescent Biopharma
CBIO
CBIO
80 hedge funds and large institutions have $123M invested in Crescent Biopharma in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
26% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 31
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
Holders
80
Holding in Top 10
–
Calls
$2.9M
Puts
$263K
Top Buyers
1 | +$5.64M | |
2 | +$582K | |
3 | +$569K | |
4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$507K |
5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$458K |
Top Sellers
1 | -$2.7M | |
2 | -$1.53M | |
3 | -$1.1M | |
4 |
Renaissance Technologies
New York
|
-$1M |
5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$555K |